Access Keys:
Skip to content (Access Key - 0)

Chordoma

Tumor biology and incidence

  • Low-grade malignant tumor
  • Generally located at base of skull (clivus), sacrum, or spine (less common)
  • Thought to arise from primitive notochordal remnants in the axial skeleton
  • Present in a central, axial-based location, most often anteriorly
  • Cumulative case count published in The Burden of Musculoskeletal Disease  (AAOS) identified 2,339 chordomas over a period of 20 years, or annual incidence of 117 chordomas in the US within the studied population
    • Other estimates as high as 300 cases per year

Age

  • Most occur in older patients,  especially those older than age 40
  • Rarely occur before age 30

Gender

M:F = 2:1

Presentation

  • Symptoms generally of long duration due to slow growth of lesion and delay in diagnosis
  • Symptoms usually nonspecific, depending on location of tumor
    • Cervical spine: Hoarseness, dysphagia, bleeding
    • Sacrum: Vague low back pain, constipation, lower extremity radiculopathy, palpable mass
      • Bowel and bladder dysfunction resulting from local organ mass effect or autonomic dysfunction
        • Autonomic dysfunction can result as the tumor compresses the adjacent sympathetic or parasympathetic outflow
  • Obtain history of treatment for degenerative disc disease or coccydynia
  • Obtain history of bowel, bladder, and sexual function

Physical findings

  • Abnormal rectal tone, perineal sensation possible
  • Soft tissue mass may be palpable on rectal exam

Plain films

  • Lesion may be missed on plain films; changes generally subtle
  • Findings may be masked by overlying abdomina/bowel gas on AP of pelvis
Site
  • Sacrococcygeal lesions
  • Spheno-occipital  lesions
  • Vertebral body lesions (in descending order of occurrence): cervical, thoracic, lumbar
Size

Slow growing lesion; can be quite large by time of diagnosis

Tumor effect on bone

Local lytic destruction of bone; extension into surrounding soft tissues

Bone response to tumor

Sclerotic, irregularly scalloped bony margin

Matrix

Calcified secondary to calcification of necrotic tissue/debris within tumor (rare)

Cortex

Cortical breakthrough (common)

Soft tissue mass

Common; more apparent on MRI than on plain films

CT scan

  • Useful for assessing degree of osseous involvement, as well as proximity of tumor mass to adjacent pelvic organs
  • Chest CT for systemic staging

MRI

  • Need multiple axes to accurately stage extent of lesion and plan surgery
  • Superior soft tissue resolution with respect to involvement of neurovascular structures within pelvis and spinal canal
  • Chordomas mucinous; lesions  typically appear hypointense on T1-weighted images and hyperintense on T2-weighted images
  • Characteristic lobular, heterogeneous features
  • Occasionally, contrast fluid-fluid levels can be identified in cystic portions of mass

Differential diagnosis

  • Metastasis
  • Chondrosarcoma
  • Myeloma
  • Lymphoma
  • Giant cell tumor

Natural history

  • Will continue to grow; symptoms related to location
  • May dedifferentiate into higher-grade lesion with sarcomatous component (rare)
  • Difficult to resect, leading to frequent local recurrence
    • Local recurrence in lumbosacral plexus devastating complication
    • Radiation plus local resection may reduce risk of local relapse
  • Metastases usually very late feature

Pathology

  • Gross:  Lobulated, myxoid tissue
  • Microscopic: Tumor cells are in sheets or cords in an abundant myxoid stroma
  • Cells often vacuolated, displacing the nucleus eccentrically
  • Physaliferous cells may be present
  • Cytological atypia may be present; no clinical significance
  • High mucin content within cytoplasm and in matrix renders a deep, eosinophilic appearance on H&E stained sections. 
  • Chondroid appearance, particularly in clival-based tumors; may indicate a better prognosis
  • Dedifferentiated form of chordoma has poor prognosis.
  • Characterized immunohistochemically by S100 and epithelial membrane antigen positivity

Diagnosis and treatment

  • Biopsy, in consultation with musculoskeletal surgical oncolgist
    • Avoid transrectal biopsy; would necessitate rectal resection and colostomy
    • Avoid tumor spillage by using posterior needle biopsy
  • Maintain of treatment: surgical resection with clear margins; chemotherapy ineffective
    • Wide resection can be curative; however 50% recurrence rate has been reported, which reduces chance of cure for patient
    • Resection of upper sacral lesions (S2 or above) carry an increased risk of blood loss, major complications, and longer ICU stays
  • Radiation therapy possibly useful in cases with microscopically positive margins of resection, palliative treatment of unresectable lesion
  • Median survival is 6 years
    • Overall survival rates: 70% at 5 years, 40% at 10 years
    • After development of metastases, median survival diminishes greatly

Recommended reading

Casali PG, Messina A, Stacchiotti S, et al. Imatinib mesylate in chordoma. Cancer. 2004 Nov 1;101(9):2086-97.

Devin C, Chong PY, Holt GE, Feurer I, Gonzalez A, Merchant N, Schwartz HS. Level-adjusted perioperative risk of sacral amputations. J Surg Oncol. 2006 Sep 1;94(3):203-11.

Bullough P, ed. Orthopaedic Pathology. 4th ed. Philadelphia, PA: Mosby, 2004.

Peer Review

OrthopaedicsOne Peer Review Workflow is an innovative platform that allows the process of peer review to occur right within an OrthopaedicsOne article in an open, transparent and flexible manner. Learn more

Instructions for Authors

Read our Instructions for Authors to learn about contributing or editing articles on OrthopaedicsOne.

Content Partner

Learn about becoming an OrthopaedicsOne Content Partner.

Academic Resources

Resources on Chordoma from Pubget.

Error rendering macro 'rss' : The RSS macro is retrieving an HTML page.
Orthopaedic Web Links

Internet resources validated by OrthopaedicWebLinks.com

Related Content

Resources on Chordoma and related topics in OrthopaedicsOne spaces.

Page: Biceps and bracialis muscle group resection (OrthopaedicsOne Articles)
Page: Buttockectomy (OrthopaedicsOne Articles)
Page: Quadriceps resection (anterior thigh) and muscle transfers (OrthopaedicsOne Articles)
Page: Adductor muscle group (medial thigh) resection (OrthopaedicsOne Articles)
Page: Hamstring muscle group (posterior thigh) resection (OrthopaedicsOne Articles)
Page: Popliteal space exploration and resections (OrthopaedicsOne Articles)
Page: Gastrocnemius and soleus muscle group resections (OrthopaedicsOne Articles)
Page: Forequarter amputation (OrthopaedicsOne Articles)
Page: Below-elbow amputations (OrthopaedicsOne Articles)
Page: Above-elbow amputations (OrthopaedicsOne Articles)
Showing first 10 of 148 results